{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:25Z","timestamp":1792787245277,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM125908-01A1"],"award-info":[{"award-number":["1R01GM125908-01A1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5R01GM088278-08"],"award-info":[{"award-number":["5R01GM088278-08"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    His-tRNA synthetase (HARS) is targeted by autoantibodies in chronic and acute inflammatory anti-Jo-1-positive antisynthetase syndrome. The extensive activation and migration of immune cells into lung and muscle are associated with interstitial lung disease, myositis, and morbidity. It is unknown whether the sequestration of HARS is an epiphenomenon or plays a causal role in the disease. Here, we show that HARS circulates in healthy individuals, but it is largely undetectable in the serum of anti-Jo-1-positive antisynthetase syndrome patients. In cultured primary human skeletal muscle myoblasts (HSkMC), HARS is released in increasing amounts during their differentiation into myotubes. We further show that HARS regulates immune cell engagement and inhibits CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell activation. In mouse and rodent models of acute inflammatory diseases, HARS administration downregulates immune activation. In contrast, neutralization of extracellular HARS by high-titer antibody responses during tissue injury increases susceptibility to immune attack, similar to what is seen in humans with anti-Jo-1-positive disease. Collectively, these data suggest that extracellular HARS is homeostatic in normal subjects, and its sequestration contributes to the morbidity of the anti-Jo-1-positive antisynthetase syndrome.\n                  <\/jats:p>","DOI":"10.1038\/s41423-019-0331-0","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T05:02:53Z","timestamp":1575435773000},"page":"1463-1475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses"],"prefix":"10.1038","volume":"18","author":[{"given":"Ryan A.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-0954","authenticated-orcid":false,"given":"C\u00e1tia","family":"Fernandes-Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Notarnicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mertsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Sze","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle P.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Ampudia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-8285","authenticated-orcid":false,"given":"Sanna","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cubitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Mendlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-084X","authenticated-orcid":false,"given":"Xiang-Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Nangle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"331_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler, M., Miller, F. W. & Fritzler, M. J. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmmun. Rev. 13, 367\u2013371 (2014).","journal-title":"Autoimmmun. Rev."},{"key":"331_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","volume":"15","author":"B Hervier","year":"2013","unstructured":"Hervier, B. & Benveniste, O. Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr. Rheumatol. Rep. 15, 349 (2013).","journal-title":"Curr. Rheumatol. Rep."},{"key":"331_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","volume":"304","author":"MB Mathews","year":"1983","unstructured":"Mathews, M. B. & Bernstein, R. M. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304, 177\u2013179 (1983).","journal-title":"Nature"},{"key":"331_CR4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.143.7.2267","volume":"143","author":"DA Ramsden","year":"1989","unstructured":"Ramsden, D. A. et al. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response. J. Immunol. 143, 2267\u20132272 (1989).","journal-title":"J. Immunol."},{"key":"331_CR5","first-page":"1598","volume":"19","author":"AA Amato","year":"2013","unstructured":"Amato, A. A. & Greenberg, S. A. Inflammatory myopathies. CONTINUUM: Lifelong Learn. Neurol. 19, 1598\u20131614 (2013).","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"331_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg, I. E., de Vissier, M. & Werth, V. P. Classification of myositis. Nat. Rev. Rheumatol. 14, 269\u2013278 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"331_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2249.1990.tb05341.x","volume":"81","author":"FW Miller","year":"1990","unstructured":"Miller, F. W., Love, L. A., Barbieri, S. A., Balow, J. E. & Plotz, P. H. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin. Exp. Immunol. 81, 373\u2013379 (1990).","journal-title":"Clin. Exp. Immunol."},{"key":"331_CR8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4049\/jimmunol.1501902","volume":"197","author":"B Hervier","year":"2016","unstructured":"Hervier, B. et al. Involvement of NK cells and NKp30 pathway in antisynthetase syndrome. J. Immunol. 197, 1621\u20131630 (2016).","journal-title":"J. Immunol."},{"key":"331_CR9","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone, K. B. et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthrit. Rheuma. 56, 3125\u20133131 (2007).","journal-title":"Arthrit. Rheuma."},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI114461","volume":"85","author":"FW Miller","year":"1990","unstructured":"Miller, F. W., Twitty, S. A., Biswas, T. & Plotz, P. H. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies. J. Clin. Invest. 85, 468\u2013475 (1990).","journal-title":"J. Clin. Invest."},{"key":"331_CR11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-015-0532-1","volume":"17","author":"DP Ascherman","year":"2015","unstructured":"Ascherman, D. P. Role of Jo-1 in the immunopathogenesis of the anti-synthetase syndrome. Curr. Rheumatol. Rep. 17, 56 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"331_CR12","volume":"3","author":"X Xu","year":"2012","unstructured":"Xu, X. et al. Unique domain appended to vertebrate tRNA synthetase is essential for vascular development. Nat. Commun. 3, 681 (2012).","journal-title":"Nat. Commun."},{"key":"331_CR13","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1073\/pnas.0802862105","volume":"105","author":"SG Park","year":"2008","unstructured":"Park, S. G., Schimmel, P. & Kim, S. Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl Acad. Sci. (USA) 105, 11043\u201311048 (2008).","journal-title":"Proc. Natl Acad. Sci. (USA)"},{"key":"331_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature21380","volume":"542","author":"A Arif","year":"2017","unstructured":"Arif, A. et al. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Nature 542, 357\u2013361 (2017).","journal-title":"Nature"},{"key":"331_CR15","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.C114.571026","volume":"289","author":"JJ Zhou","year":"2014","unstructured":"Zhou, J. J. et al. Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis. J. Biol. Chem. 289, 19269\u201319275 (2014).","journal-title":"J. Biol. Chem."},{"key":"331_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/CVI.00594-12","volume":"20","author":"MA Kron","year":"2013","unstructured":"Kron, M. A., Metwali, A., Vodanovic-Jankovic, S. & Elliott, D. Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T cell transfer colitis. Clin. Vacc. Immunol. 20, 276\u2013281 (2013).","journal-title":"Clin. Vacc. Immunol."},{"key":"331_CR17","doi-asserted-by":"crossref","first-page":"16191","DOI":"10.1038\/nmicrobiol.2016.191","volume":"2","author":"YH Ahn","year":"2016","unstructured":"Ahn, Y. H. et al. Secreted tryptophanyl-tRNA synthetase as a primary defence system against infection. Nat. Microbiol. 2, 16191 (2016).","journal-title":"Nat. Microbiol."},{"key":"331_CR18","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1083\/jcb.201605118","volume":"216","author":"SB Kim","year":"2017","unstructured":"Kim, S. B. et al. Caspase-8 controls the secretion of inflammatory lysyl-tRNA synthetase in exosomes from cancer cells. J. Cell Biol. 216, 2201\u20132216 (2017).","journal-title":"J. Cell Biol."},{"key":"331_CR19","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1073\/pnas.1200194109","volume":"109","author":"MC Park","year":"2012","unstructured":"Park, M. C. et al. Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc. Natl Acad. Sci. (USA) 109, E640\u2013E647 (2012).","journal-title":"Proc. Natl Acad. Sci. (USA)"},{"key":"331_CR20","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.str.2012.08.001","volume":"20","author":"Z Xu","year":"2012","unstructured":"Xu, Z. et al. Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing. Structure 20, 1470\u20131477 (2012).","journal-title":"Structure"},{"key":"331_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen, L. et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J. Exp. Med. 201, 591\u2013601 (2005).","journal-title":"J. Exp. Med."},{"key":"331_CR22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1252943","volume":"345","author":"WS Lo","year":"2014","unstructured":"Lo, W. S. et al. Human tRNA synthetase catalytic nulls with diverse functions. Science 345, 328\u2013332 (2014).","journal-title":"Science"},{"key":"331_CR23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","volume":"162","author":"M Hirakata","year":"1999","unstructured":"Hirakata, M. et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J. Immunol. 162, 2315\u20132320 (1999).","journal-title":"J. Immunol."},{"key":"331_CR24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.144.5.1737","volume":"144","author":"IN Targoff","year":"1990","unstructured":"Targoff, I. N. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J. Immunol. 144, 1737\u20131743 (1990).","journal-title":"J. Immunol."},{"key":"331_CR25","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.4049\/jimmunol.138.9.2874","volume":"138","author":"IN Targoff","year":"1987","unstructured":"Targoff, I. N. & Reichlin, M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J. Immunol. 138, 2874\u20132882 (1987).","journal-title":"J. Immunol."},{"key":"331_CR26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780230802","volume":"23","author":"M Nishikai","year":"1980","unstructured":"Nishikai, M. & Reichlin, M. Heterogeneity of precipitating antibodies in ploymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthrit. Rheuma. 23, 881\u2013888 (1980).","journal-title":"Arthrit. Rheuma."},{"key":"331_CR27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat. Cell Biol. 3, 1009\u20131013 (2001).","journal-title":"Nat. Cell Biol."},{"key":"331_CR28","first-page":"481","volume":"17","author":"JR Florini","year":"1996","unstructured":"Florini, J. R., Ewton, D. Z. & Coolican, S. A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17, 481\u2013517 (1996).","journal-title":"Endocr. Rev."},{"key":"331_CR29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","volume":"29","author":"Y Katsumatu","year":"2007","unstructured":"Katsumatu, Y. et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J. Autoimmun. 29, 174\u2013186 (2007).","journal-title":"J. Autoimmun."},{"key":"331_CR30","doi-asserted-by":"crossref","first-page":"879703","DOI":"10.1155\/2014\/879703","volume":"2014","author":"C Sciorati","year":"2014","unstructured":"Sciorati, C. et al. 7-Tesla magnetic resonance imaging precisely and non-invasively reflects inflammation and remodeling of the skeletal muscle in a mouse model of anti-synthetase syndrome. Biomed. Res. Int. 2014, 879703 (2014).","journal-title":"Biomed. Res. Int."},{"key":"331_CR31","doi-asserted-by":"crossref","first-page":"E8228","DOI":"10.1073\/pnas.1807000115","volume":"115","author":"T Kanaji","year":"2018","unstructured":"Kanaji, T. et al. Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia. Proc. Natl Acad. Sci. USA 115, E8228\u2013E8235 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"331_CR32","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1074\/jbc.C110.213876","volume":"286","author":"MN Vo","year":"2011","unstructured":"Vo, M. N., Yang, X. L. & Schimmel, P. Dissociating quaternary structure regulates cell-signaling functions of a secreted human tRNA synthetase. J. Biol. Chem. 286, 11563\u201311568 (2011).","journal-title":"J. Biol. Chem."},{"key":"331_CR33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn, T. A. Integrating mechanisms off pulmonary fibrosis. J. Exp. Med. 208, 1339\u20131350 (2011).","journal-title":"J. Exp. Med."},{"key":"331_CR34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","volume":"56","author":"RG Jenkins","year":"2017","unstructured":"Jenkins, R. G. et al. ATS assembly on respiratory cell and molecular biology. An Official American Thoracic Society Workshop Report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. Am. J. Resp. Cell Mol. Biol. 56, 667\u2013679 (2017).","journal-title":"Am. J. Resp. Cell Mol. Biol."},{"key":"331_CR35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","volume":"194","author":"WH Schaefer","year":"2004","unstructured":"Schaefer, W. H. et al. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Tox. Appl. Pharmacol. 194, 10\u201323 (2004).","journal-title":"Tox. Appl. Pharmacol."},{"key":"331_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/toxsci\/kfi305","volume":"88","author":"JL Seachrist","year":"2005","unstructured":"Seachrist, J. L., Loi, C. M., Evans, M. G., Criswell, K. A. & Rothwell, C. E. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Tox. Sci. 88, 551\u2013561 (2005).","journal-title":"Tox. Sci."},{"key":"331_CR37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1734-1140(11)70601-6","volume":"63","author":"M Tomaszewski","year":"2011","unstructured":"Tomaszewski, M., Stepien, K. M., Tomaszewska, J. & Czuczwar, S. J. Statin-induced myopathies. Pharmacol. Rep. 63, 859\u2013866 (2011).","journal-title":"Pharmacol. Rep."},{"key":"331_CR38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","volume":"196","author":"OM Howard","year":"2002","unstructured":"Howard O. M. et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J. Exp. Med. 196, 781\u2013791 (2002).","journal-title":"J. Exp. Med."},{"key":"331_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","volume":"17","author":"JG Tidball","year":"2017","unstructured":"Tidball, J. G. Regulation of muscle growth and regeneration by the immune system. Nat. Rev. Immunol. 17, 165\u2013178 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"331_CR40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fphys.2018.00768","volume":"9","author":"MR Deyhle","year":"2018","unstructured":"Deyhle, M. R. & Hyldahl, R. D. The role of T lymphocytes in skeletal muscle repair from traumatic and contraction-induced injury. Front Physiol. 9, 768 (2018).","journal-title":"Front Physiol."},{"key":"331_CR41","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.1303486","volume":"193","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. CD8 T cells are involved in skeletal muscle regeneration through facilitating MCP-1 secretion and Gr1(high) macrophage infiltration. J. Immunol. 193, 5149\u20135160 (2014).","journal-title":"J. Immunol."},{"key":"331_CR42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/hum.1997.8.12-1469","volume":"8","author":"LM Blechynden","year":"1997","unstructured":"Blechynden, L. M. et al. Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase. Hum. Gen. Ther. 8, 1469\u20131480 (1997).","journal-title":"Hum. Gen. Ther."},{"key":"331_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36395-z","volume":"8","author":"C Fernandes-Cerqueira","year":"2018","unstructured":"Fernandes-Cerqueira, C. et al. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies. Sci. Rep. 8, 17958 (2018).","journal-title":"Sci. Rep."},{"key":"331_CR44","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","volume":"138","author":"L Mescam-Mancini","year":"2015","unstructured":"Mescam-Mancini, L. et al. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain 138, 2485\u20132492 (2015).","journal-title":"Brain"},{"key":"331_CR45","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","volume":"56","author":"ML Eloranta","year":"2007","unstructured":"Eloranta, M. L. et al. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies. Arthritis Rheum. 56, 3112\u20133124 (2007).","journal-title":"Arthritis Rheum."},{"key":"331_CR46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nchembio.1158","volume":"9","author":"M Guo","year":"2013","unstructured":"Guo, M. & Schimmel, P. Essential nontranslational functions of tRNA synthetases. Nat. Chem. Biol. 9, 145\u2013153 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"331_CR47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344\u2013347 (1975).","journal-title":"N. Engl. J. Med."},{"key":"331_CR48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs, R. C. et al. Inclusion body myositis and myopathies. Ann. Neurol. 38, 705\u2013713 (1995).","journal-title":"Ann. Neurol."},{"key":"331_CR49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0331-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:41:13Z","timestamp":1695472873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-019-0331-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1038\/s41423-019-0331-0","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"28 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}